Of these HCC cases, 54 (~40%) were classified as FOXM1-high (>25% of nuclei stained with anti-FOXM1 antibody) and 79 (~60%) were defined as FOXM1-low (≤25% of nuclei stained). This evidence concerns the gene FOXM1 and hepatocellular carcinoma.